Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm VebfiledCriticalJenapharm Veb
Publication of BE749658ApublicationCriticalpatent/BE749658A/en
Steroids of the estratriene series of general formula (I) R1 = H, acyl, tetrahydropyranyl or N-phenyl-carbamoyl R2 = thiocyano, azido, cyano, mercapto, alkylmercapto, arylmercapto, acylmercapto, halogen, alkoxy, aryloxy, acyloxy, substd. amino (and its salts) or OH. The cpds. are biologically and pharmacologically active. 3-methoxy-17alpha-thiocyanomethyl-estra-1,3,5(10)-trien-17beta-ol (645 mg).
The manufacture of 4,6-dichloro-16-methylene-17alpha-hydroxy-pregna-4,6-diene-3,20-dione and the new 4,6-dichloro-16beta-chloromethyl-16alpha,17alpha-epoxy-pregna-4,6-diene-3,20dione
Novel 1,2-methylene-17-acyloxy(or improved hydroxy)-9beta,10alpha-steroid compounds of the pregnane series,pharmaceutical preparations on the basis of the novel compounds and methods of producing said compounds and preparations